2023 -now Executive Committee Member, European Federation of Medicinal Chemistry and Chemical Biology @
2023 -now Editor, Progress in Medicinal Chemistry @
2024 -2026 CSO and COO GIO Therapeutics @
2018 -2024 Elected Member of the RSC Organic Chemistry Community @
2023 -2023 Chief Scientific Officer @
2020 -2023 VP of Science @
2018 -2020 VP of Medicinal Chemistry and Site Director @
2017 -2018 Head of Research and Operations @
2016 -2017 Executive Director of Oncology and Immunology @
2014 -2016 Head of Medicinal Chemistry @
2012 -2014 Team Leader, Medicinal Chemistry @
2011 -2012 Medicinal Chemist @ maternity leave
2009 -2011 Team Leader, Medicinal Chemistry @
2007 -2009 Team Leader, Medicinal Chemistry @
2002 -2007 Team Leader, Medicinal Chemistry @
2001 -2002 Post Doctoral Researcher @
2000 -2001 Post Doctoral researcher @ CNRS, Institut de Chimie des Substances Naturelles
Tilly Bingham Education
UCL
Ph.D (Organic Chemistry)
1996-2000
Imperial College London
BSc (Chemistry with a year in Europe)
1992-1996
Tilly Bingham Summary
Tilly Bingham, based in Manchester, England, GB, is currently a CSO (GPCR Therapeutics) Cumulus Oncology at Cumulus Oncology. Tilly Bingham brings experience from previous roles at Cumulus Oncology, EFMC - European Federation for Medicinal Chemistry and Chemical Biology, Elsevier and GIO Therapeutics. Tilly Bingham holds a 1996 - 2000 Ph.D in Organic Chemistry @ UCL. Tilly Bingham has 3 emails on RocketReach.
Looking for a different Tilly Bingham?
Find contact details for 700 million professionals.